Dr Mike Yeadon bio
Has a degree in biochemistry and toxicology and a research-based PhD in respiratory pharmacology. He has spent over 30 years leading new medicines research in some of the world’s largest pharmaceutical companies, leaving Pfizer…
Dr Mike Yeadon bio
Has a degree in biochemistry and toxicology and a research-based PhD in respiratory pharmacology. He has spent over 30 years leading new medicines research in some of the world’s largest pharmaceutical companies, leaving Pfizer in 2011 as Vice President & Chief Scientist for Allergy & Respiratory. That was the most senior research position in this field in Pfizer. Since leaving Pfizer, Dr Yeadon has founded his own biotech company, Ziarco, which was sold to the worlds biggest drug company, Novartis, in 2017.
Re_Uploaded from Pandemic Podcast
As we emerge, slowly, and conditionally, from our latest lockdown, it can be easy to feel that such restrictions are a thing of the past. But we only have to look across the Channel — where there’s increasing talk of a ‘third wave’ and new variants — to see that this could be far from the truth.
My guest today is Dr Mike Yeadon, an independent biotech consultant with 32 years of experience in research and development with big pharma — including Pfizer at senior management level — and within biotechnology as a company founder.
Within this episode we will be exploring some of the pertinent issues around lockdowns, vaccine passports and the mass vaccination programme.
We’ll also be exploring whether the issue of ‘variants’ will become a likely cause of future lockdowns, and the implication this has for a potentially unending series of vaccine top-ups and boosters.
Please subscribe to the Pandemic Podcast at http://www.dangregory.com/pandemic
SOCIAL MEDIA:
FACEBOOK: https://www.facebook.com/danjgregory
TWITTER: https://twitter.com/danjgregory
INSTAGRAM: https://www.instagram.com/danjgregory
